Profile data is unavailable for this security.
About the company
Odi Pharma AB (publ) is a Swedish-based pharmaceutical company. The Company is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. The Company is located in Stockholm.
- Revenue in SEK (TTM)818.38k
- Net income in SEK-3.97m
- Incorporated2019
- Employees--
- LocationOdi Pharma AB (publ)Ostermalmstorg 1STOCKHOLM 11442SwedenSWE
- Websitehttps://www.odipharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spago Nanomedical AB (publ) | 1.20m | -42.22m | 68.31m | 13.00 | -- | 1.62 | -- | 56.79 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Abera Bioscience AB | 0.00 | -16.72m | 73.54m | -- | -- | 12.25 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
| Combigene AB | 5.54m | -35.67m | 73.66m | 11.00 | -- | 0.6325 | -- | 13.29 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 504,000.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.33 | -58.77 | -- | -- | -- | -- | -79.24 | 268.58 | -479.27 | -- | -- | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 74.94m | -- | -- | 3.12 | -- | 36.43 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 76.47m | -- | -- | 0.2203 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
| Alzinova AB | 270.00k | -16.48m | 83.36m | -- | -- | 0.7322 | -- | 308.75 | -0.4149 | -0.4149 | 0.0067 | 2.56 | 0.0023 | -- | 0.3671 | -- | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.55 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 83.71m | -- | -- | 41.11 | -- | 102.29 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 87.08m | -- | -- | 0.5321 | -- | 2.02 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| NextCell Pharma AB | 12.22m | -40.69m | 88.70m | -- | -- | 1.35 | -- | 7.26 | -1.18 | -1.18 | 0.3555 | 1.92 | 0.124 | 14.66 | 6.80 | -- | -41.28 | -34.92 | -45.63 | -37.06 | 6.61 | -68.21 | -332.90 | -538.60 | 4.97 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| Sprint Bioscience AB | 50.49m | -441.00k | 93.28m | 28.00 | -- | 3.36 | 13,325.66 | 1.85 | -0.0064 | -0.0064 | 0.7232 | 0.3978 | 1.01 | -- | 7.58 | 1,803,036.00 | -0.8838 | -71.22 | -1.58 | -113.71 | 82.77 | 62.75 | -0.8735 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Immunovia AB (publ) | 1.58m | -309.44m | 93.52m | 11.00 | -- | 1.40 | -- | 59.38 | -8.27 | -8.27 | 0.0412 | 1.48 | 0.0079 | 74.81 | 7.89 | 143,181.80 | -155.00 | -41.33 | -179.24 | -44.24 | -4,687.68 | -7,553.76 | -19,646.92 | -20,879.26 | 2.69 | -22.84 | 0.1329 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 93.92m | 4.00 | -- | 14.80 | -- | -- | -0.1887 | -0.1887 | 0.00 | 0.0183 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Ziccum AB | 3.75m | -21.41m | 97.26m | 8.00 | -- | 10.24 | -- | 25.96 | -1.54 | -1.54 | 0.2701 | 0.6191 | 0.1553 | -- | 2.01 | 468,375.00 | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
| Wntresearch AB | 0.00 | -32.47m | 97.86m | 2.00 | -- | 0.6161 | -- | -- | -0.1108 | -0.1108 | 0.00 | 0.1834 | 0.00 | -- | -- | -- | -134.87 | -100.71 | -166.68 | -123.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.65 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.46m | 98.54m | -- | -- | 0.6419 | -- | -- | -0.0597 | -0.0597 | 0.00 | 0.779 | 0.00 | -- | -- | -- | -5.21 | -7.45 | -5.43 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Bactiquant A/S | 19.13m | -20.37m | 99.01m | -- | -- | 4.42 | -- | 5.18 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Data as of Apr 22 2024. Currency figures normalised to Odi Pharma AB (publ)'s reporting currency: Swedish Krona SEK
